§ 44–109.02. Pre-admission medication management assessment.

Within 30 days prior to admission, the ALR shall consult with the prospective resident’s healthcare practitioner regarding:

(1) The prospective resident’s current medication profile, including a review of nonprescription drugs;

(2) Possible adverse interactions;

(3) Common expected or unexpected side effects; and

(4) The potential that such medications have to act as chemical restraints.